ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 37 filers reported holding ELEDON PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $303,908 | -41.9% | 221,830 | 0.0% | 0.05% | -59.7% |
| Q1 2023 | $523,518 | +1.7% | 221,830 | 0.0% | 0.12% | -4.0% |
| Q4 2022 | $514,645 | -15.9% | 221,830 | 0.0% | 0.12% | +1.6% |
| Q3 2022 | $612,000 | -30.8% | 221,830 | -38.8% | 0.12% | -24.2% |
| Q2 2022 | $884,000 | -38.1% | 362,537 | 0.0% | 0.16% | -14.4% |
| Q1 2022 | $1,429,000 | -5.9% | 362,537 | +5.2% | 0.19% | -16.8% |
| Q4 2021 | $1,519,000 | -28.7% | 344,578 | 0.0% | 0.23% | +50.7% |
| Q3 2021 | $2,129,000 | -23.1% | 344,578 | -1.5% | 0.15% | -33.0% |
| Q2 2021 | $2,769,000 | +3.5% | 350,000 | +40.0% | 0.22% | +148.9% |
| Q1 2021 | $2,676,000 | – | 250,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 245,000 | $676,000 | 0.76% |
| BVF INC/IL | 2,326,710 | $6,422,000 | 0.26% |
| Cormorant Asset Management, LP | 1,223,500 | $3,377,000 | 0.24% |
| Ikarian Capital, LLC | 221,830 | $612,000 | 0.12% |
| JMAC ENTERPRISES LLC | 54,538 | $151,000 | 0.04% |
| Woodline Partners LP | 516,675 | $1,426,000 | 0.02% |
| Eversept Partners, LP | 67,743 | $186,971 | 0.02% |
| INGALLS & SNYDER LLC | 51,149 | $141,000 | 0.01% |
| Point72 Asset Management, L.P. | 375,000 | $1,035,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 22,050 | $61,000 | 0.00% |